320 related articles for article (PubMed ID: 34190268)
1. Anticancer activity of a new copper(II) complex with a hydrazone ligand. Structural and spectroscopic characterization, computational simulations and cell mechanistic studies on 2D and 3D breast cancer cell models.
Balsa LM; Ferraresi-Curotto V; Lavecchia MJ; Echeverría GA; Piro OE; García-Tojal J; Pis-Diez R; González-Baró AC; León IE
Dalton Trans; 2021 Jul; 50(28):9812-9826. PubMed ID: 34190268
[TBL] [Abstract][Full Text] [Related]
2. Anticancer and antimetastatic activity of copper(II)-tropolone complex against human breast cancer cells, breast multicellular spheroids and mammospheres.
Balsa LM; Ruiz MC; Santa Maria de la Parra L; Baran EJ; León IE
J Inorg Biochem; 2020 Mar; 204():110975. PubMed ID: 31911364
[TBL] [Abstract][Full Text] [Related]
3. Anticancer Activity and Mechanism of Action Evaluation of an Acylhydrazone Cu(II) Complex toward Breast Cancer Cells, Spheroids, and Mammospheres.
Balsa LM; Rodriguez MR; Parajón-Costa BS; González-Baró AC; Lavecchia MJ; León IE
ChemMedChem; 2022 Feb; 17(4):e202100520. PubMed ID: 34750978
[TBL] [Abstract][Full Text] [Related]
4. Mixed-ligand Cu(II) hydrazone complexes designed to enhance anticancer activity.
Mo Q; Deng J; Liu Y; Huang G; Li Z; Yu P; Gou Y; Yang F
Eur J Med Chem; 2018 Aug; 156():368-380. PubMed ID: 30015073
[TBL] [Abstract][Full Text] [Related]
5. The Cu/ligand stoichiometry effect on the coordination behavior of aroyl hydrazone with copper(II): Structure, anticancer activity and anticancer mechanism.
Deng J; Gou Y; Chen W; Fu X; Deng H
Bioorg Med Chem; 2016 May; 24(10):2190-8. PubMed ID: 27056799
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antitumor mechanisms of a copper(II) complex of anthracene-9-imidazoline hydrazone (9-AIH).
Qin QP; Liu YC; Wang HL; Qin JL; Cheng FJ; Tang SF; Liang H
Metallomics; 2015 Jul; 7(7):1124-36. PubMed ID: 25904543
[TBL] [Abstract][Full Text] [Related]
7. Immunogenic Cell Death of Breast Cancer Stem Cells Induced by an Endoplasmic Reticulum-Targeting Copper(II) Complex.
Kaur P; Johnson A; Northcote-Smith J; Lu C; Suntharalingam K
Chembiochem; 2020 Dec; 21(24):3618-3624. PubMed ID: 32776422
[TBL] [Abstract][Full Text] [Related]
8. New copper(II) and oxidovanadium(IV) complexes with a vitamin B
Balsa LM; Ferretti V; Sottile M; Nunes P; Costa Pessoa J; Correia I; León IE
Dalton Trans; 2024 Feb; 53(7):3039-3051. PubMed ID: 38111362
[TBL] [Abstract][Full Text] [Related]
9. Isoxazole-Derived Aroylhydrazones and Their Dinuclear Copper(II) Complexes Show Antiproliferative Activity on Breast Cancer Cells with a Potentially Alternative Mechanism Of Action.
Rada JP; Forté J; Gontard G; Corcé V; Salmain M; Rey NA
Chembiochem; 2020 Sep; 21(17):2474-2486. PubMed ID: 32282111
[TBL] [Abstract][Full Text] [Related]
10. Interaction with CT-DNA and in vitro cytotoxicity of two new copper(II)-based potential drugs derived from octanoic hydrazide ligands.
Chowdhury M; Biswas N; Saha S; Rahaman A; Gupta PS; Banerjee A; Mandal DP; Bhattacharjee S; Zangrando E; Sciortino G; Pisanu F; Garribba E; Roy Choudhury R; Roy Choudhury C
J Inorg Biochem; 2024 Jul; 256():112546. PubMed ID: 38593611
[TBL] [Abstract][Full Text] [Related]
11. Efficient hydrolytic cleavage of DNA and antiproliferative effect on human cancer cells by two dinuclear Cu(II) complexes containing a carbohydrazone ligand and 1,10-phenanthroline as a coligand.
Parsekar SU; Singh M; Mishra DP; Antharjanam PKS; Koley AP; Kumar M
J Biol Inorg Chem; 2019 May; 24(3):343-363. PubMed ID: 30887122
[TBL] [Abstract][Full Text] [Related]
12. Copper(ii) complexes with tridentate halogen-substituted Schiff base ligands: synthesis, crystal structures and investigating the effect of halogenation, leaving groups and ligand flexibility on antiproliferative activities.
Kordestani N; Amiri Rudbari H; Fernandes AR; Raposo LR; Luz A; Baptista PV; Bruno G; Scopelliti R; Fateminia Z; Micale N; Tumanov N; Wouters J; Abbasi Kajani A; Bordbar AK
Dalton Trans; 2021 Mar; 50(11):3990-4007. PubMed ID: 33650599
[TBL] [Abstract][Full Text] [Related]
13. A novel binuclear hydrazone-based Cd(II) complex is a strong pro-apoptotic inducer with significant activity against 2D and 3D pancreatic cancer stem cells.
Bjelogrlić S; Todorović TR; Cvijetić I; Rodić MV; Vujčić M; Marković S; Araškov J; Janović B; Emhemmed F; Muller CD; Filipović NR
J Inorg Biochem; 2019 Jan; 190():45-66. PubMed ID: 30352315
[TBL] [Abstract][Full Text] [Related]
14. Octahedral copper(ii)-diimine complexes of triethylenetetramine: effect of stereochemical fluxionality and ligand hydrophobicity on Cu
Sharma M; Ganeshpandian M; Majumder M; Tamilarasan A; Sharma M; Mukhopadhyay R; Islam NS; Palaniandavar M
Dalton Trans; 2020 Jun; 49(24):8282-8297. PubMed ID: 32510543
[TBL] [Abstract][Full Text] [Related]
15. Selective anticancer copper(II)-mixed ligand complexes: targeting of ROS and proteasomes.
Ng CH; Kong SM; Tiong YL; Maah MJ; Sukram N; Ahmad M; Khoo AS
Metallomics; 2014 Apr; 6(4):892-906. PubMed ID: 24549332
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, Characterization and Biological Evaluation of Metal Adamantyl 2-Pyridylhydrazone Complexes.
Shehadi IA; Delmani FA; Jaber AM; Hammad H; AlDamen MA; Al-Qawasmeh RA; Khanfar MA
Molecules; 2020 May; 25(11):. PubMed ID: 32485892
[TBL] [Abstract][Full Text] [Related]
17. Cu(II)-acylhydrazone complex, a potent and selective antitumor agent against human osteosarcoma: Mechanism of action studies over in vitro and in vivo models.
Balsa LM; Solernó LM; Rodriguez MR; Parajón-Costa BS; Gonzalez-Baró AC; Alonso DF; Garona J; León IE
Chem Biol Interact; 2023 Oct; 384():110685. PubMed ID: 37666443
[TBL] [Abstract][Full Text] [Related]
18. Investigation into antiproliferative activity and apoptosis mechanism of new arene Ru(ii) carbazole-based hydrazone complexes.
Sathiya Kamatchi T; Mohamed Subarkhan MK; Ramesh R; Wang H; Małecki JG
Dalton Trans; 2020 Aug; 49(32):11385-11395. PubMed ID: 32776042
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of Dipyridyl Ketone Isonicotinoyl Hydrazone Copper(II) Complex: Structure, Anticancer Activity and Anticancer Mechanism.
Deng J; Chen W; Deng H
J Fluoresc; 2016 Nov; 26(6):1987-1996. PubMed ID: 27488686
[TBL] [Abstract][Full Text] [Related]
20. Selective Cu(I) complex with phosphine-peptide (SarGly) conjugate contra breast cancer: Synthesis, spectroscopic characterization and insight into cytotoxic action.
Komarnicka UK; Kozieł S; Starosta R; Kyzioł A
J Inorg Biochem; 2018 Sep; 186():162-175. PubMed ID: 29945023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
